Show Summary Details
Page of

Estimating prognosis 

Estimating prognosis
Estimating prognosis

Roy S. Gardner

, Theresa A. McDonagh

, and Niki L. Walker

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 February 2020

With advances in medical therapy, the prognosis of CHF has improved dramatically. However, some patients remain symptomatic and at high risk of death despite maximal medical therapy, and identifying these individuals, who would potentially benefit from a range of novel device therapies or cardiac transplantation, can be challenging. Over 300 parameters have been shown to be predictive of a poor outcome in patients with CHF, the most consistent of which will be illustrated in this chapter. To date, the most effective single marker appears to be the B-type natriuretic peptides (BNP/NT-proBNP).

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.